Allan-Herndon-Dudley syndrome: Clinical Trials

11 trials for Allan-Herndon-Dudley syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 1 active not recruiting, 1 approved for marketing. 3 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Completed 1, Unknown 1
Phase 32Completed 1, Unknown 1

Follow Allan-Herndon-Dudley syndrome: new trials by email Literature Review of Allan-Herndon-Dudley syndrome trials Research Report on Allan-Herndon-Dudley syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)
Tiratricol, Placebo - Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome
Phase 3CompletedRare Thyroid Therapeutics International AB202023-07-212026-04-08
MCT8 Deficiency Caregiver Study
Monocarboxylate Transporter 8 (MCT8) Deficiency, Allan-Herndon-Dudley Syndrome
CompletedRare Thyroid Therapeutics International AB212022-08-232024-04-25
Register for Patients With Thyroid Hormone Resistance.
no intervention - Hypothyroidism, Global Developmental Delay
RecruitingCharite University, Berlin, Germany2002021-07-012024-08-22
Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome)
Glycerol Phenylbutyrate 1100 MG/ML - Monocarboxylate Transporter 8 Deficiency
Phase 2 / Phase 3UnknownKaplan Medical Center62021-06-302021-08-24
Triac Trial II in MCT8 Deficiency Patients
Tiratricol - Allan-Herndon-Dudley Syndrome
Phase 2Active not recruitingRare Thyroid Therapeutics International AB222020-12-072026-02-20
GROWing Up With Rare GENEtic Syndromes
Retrospective file studies - Prader-Willi Syndrome, PWS-like Syndrome
Recruitingdr. Laura C. G. de Graaff-Herder6002018-10-012023-09-06
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Leukodystrophy, White Matter Disease
CompletedChildren's Hospital of Philadelphia2362017-01-062025-11-10
The Myelin Disorders Biorepository Project
Leukodystrophy, White Matter Disease
RecruitingChildren's Hospital of Philadelphia120002016-12-082025-10-23
Thyroid Hormone Analog Therapy in MCT8 Deficiency: Triac Trial Patients
Triac - Allan-Herndon-Dudley Syndrome
Phase 2CompletedErasmus Medical Center462014-10-012019-04-16
Rescue of Infants With MCT8 Deficiency
Diiodothyropropionic acid (DITPA) - Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency
AvailableRoy E. Weiss, M.D.2025-12-11
Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency
Tiratricol - Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome
Approved for marketingRare Thyroid Therapeutics International AB2026-10-06

Narrower conditions

Adrenoleukodystrophy (2)  ·  Aicardi-Goutieres syndrome (2)  ·  Alexander Disease (2)  ·  Alexanders leukodystrophy (2)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  CADASIL (2)  ·  Canavan Disease (2)  ·  Charcot-Marie-Tooth Disease (2)  ·  Cockayne Syndrome (2)  ·  Gangliosidoses (2)  ·  Gangliosidoses, GM2 (2)  ·  Leukodystrophy, Globoid Cell (2)  ·  Leukodystrophy, Hypomyelinating, 5 (2)  ·  Leukodystrophy, Hypomyelinating, 6 (2)

Broader conditions

Congenital Abnormalities (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Endocrine System Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Nervous System Diseases (4)  ·  Nervous System Malformations (4)  ·  Neurobehavioral Manifestations (4)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Abnormalities, Multiple (3)  ·  Adrenal Gland Diseases (3)  ·  Bone Diseases (3)  ·  Bone Diseases, Developmental (3)  ·  Brain Diseases (3)  ·  Cardiovascular Diseases (3)

Interventions

3,3',5-triiodothyroacetic acid (4)  ·  3,5-diiodothyropropionic acid (1)  ·  glycerol phenylbutyrate (1)

Sponsors

Rare Thyroid Therapeutics International AB (4)  ·  Children's Hospital of Philadelphia (2)  ·  Charite University, Berlin, Germany (1)  ·  Erasmus Medical Center (1)  ·  Kaplan Medical Center (1)  ·  Roy E. Weiss, M.D. (1)  ·  dr. Laura C. G. de Graaff-Herder (1)

Countries

United States (6)  ·  Netherlands (4)  ·  Germany (2)  ·  United Kingdom (2)  ·  Czechia (1)  ·  Israel (1)

Top investigators

Adeline Vanderver, MD (2)  ·  Amnon Zung, MD (1)  ·  Andrew Bauer, MD (1)  ·  Andrew J. Bauer, MD (1)  ·  Heiko Krude (1)  ·  Heiko Krude, MD (1)  ·  Jan Lebl (1)  ·  Lindsey Nicol (1)  ·  Mark Larkin, PhD (1)  ·  Roy E Weiss, M.D. (1)  ·  W. E. Visser, MD (1)  ·  W.E. Visser, MD, PhD (1)  ·  W.E. Visser, dr, (1)

Results publications

PMID 31377265, PMID 32342562, PMID 32749716, PMID 34969638, PMID 37881807, PMID 38469646

NIH funding

2014 (1), U01NS106845 (1), U54NS115052 (1)